Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria

Por Pérez-Larraya, Jaime Gállego, Lahutte, Marion, Petrirena, Gregorio, Reyes-Botero, Germán, González-Aguilar, Alberto, Houillier, Caroline, Guillevin, Rémy, Sanson, Marc, Hoang-Xuan, Khê, Delattre, Jean-Yves
Publicado em 2012

Cytotoxicity induced by carbon nanotubes in experimental malignant glioma

Por Romano-Feinholz, Samuel, Salazar-Ramiro, Alelí, Muñoz-Sandoval, Emilio, Magaña-Maldonado, Roxana, Hernández Pedro, Norma, Rangel López, Edgar, González Aguilar, Alberto, Sánchez García, Aurora, Sotelo, Julio, Pérez de la Cruz, Verónica, Pineda, Benjamín
Publicado no Int J Nanomedicine (2017)

Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report

Por Taylor, Jennie W., Flanagan, Eoin P., O'Neill, Brian P., Siegal, Tali, Omuro, Antonio, DeAngelis, Lisa, Baehring, Joachim, Nishikawa, Ryo, Pinto, Fernando, Chamberlain, Marc, Hoang-Xuan, Khe, Gonzalez-Aguilar, Alberto, Batchelor, Tracy, Blay, Jean-Yves, Korfel, Agnieszka, Betensky, Rebecca A., Lopes, Maria-Beatriz S., Schiff, David
Publicado em 2013